Access TCA was tasked with creating an eye catching, engaging, brand experience for the premier of Novartis' breakthrough new heart failure drug: Entresto.

“Our design was meant to be a 3 dimensional embodiment of the Entresto brand itself. In addition to the premier of this new therapy at AHA 2015 there was also a disease state component to the exhibit aimed at further educating healthcare professionals on the risk factors associated with heart disease.”